QuidelOrtho Corporation - Common Stock (QDEL)

China sales slump and a restructuring plan reshape the outlook

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 11.6% year on year to $618....

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

QuidelOrtho (NASDAQ:QDEL) reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results. The company said revenue rose 3% excluding China, respiratory testing and the

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q3 2026, with revenue falling 11.6% year on year to $61...

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting results this Tuesday after market hours. Here’s what to expect. QuidelOrtho beat a...

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack ...

What Happened? A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields r...

Over the past six months, QuidelOrtho’s shares (currently trading at $13.31) have posted a disappointing 17.3% loss, well below the S&P 500’s 12.8% gain. Thi...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

China headwinds and respiratory uncertainty weigh on full-year guidance.

QuidelOrtho’s second quarter results were met with a negative market reaction, reflecting investor concern over significant challenges in key markets. While ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year...

QuidelOrtho (NASDAQ:QDEL) reported second-quarter revenue growth despite continued pressure from China and a softer respiratory testing environment, while lowering its full-year outlook and withdrawing free cash flow guidance. Total second-quarter revenue was $631 million, up 2% on a constant-curre

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.8% year on y...